CM-Path Discovery workstream held ‘The Liquid Biopsy’ Symposium on March 8th 2018.

Following the day members of CM-Path worked in collaboration with CRUK and PHG Foundation to develop a consensus statement.

» Download our Consensus Statement on What is the role of pathologists in the implementation of liquid biopsy technologies? (PDF)

 

The Consensus Statement was written in collaboration with:

» Cancer Research UK Precision Medicine Team (External Webpage)

» PHG Foundation (External Webpage)

The PHG Foundation, part of the University of Cambridge, is a non-profit think tank focused on how emerging health technologies can provide more effective, personalised healthcare for patients and citizens.

The Cancer Research UK Precision Medicine team is pioneering a number of collaborative initiatives which aim to tailor treatment and care to individual patients based on the molecular specific make-up of their disease cancer.